Brian Rowe
Corporate Officer/Principal bei ATEA PHARMACEUTICALS, INC.
Profil
Brian Rowe is currently the Vice President of Business Development at Atea Pharmaceuticals, Inc. He previously worked as the Senior Director of Business Development at Radius Health, Inc. and as the Senior Director of Marketing Operations at Tesaro, Inc. Mr. Rowe completed his undergraduate degree at Bowdoin College and holds an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Brian Rowe
Unternehmen | Position | Beginn |
---|---|---|
ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Brian Rowe
Unternehmen | Position | Ende |
---|---|---|
TESARO INC | Sales & Marketing | - |
RADIUS HEALTH, INC. | Corporate Officer/Principal | - |
Ausbildung von Brian Rowe
Bowdoin College | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ATEA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |